Novo Nordisk Free Cash Flow 2010-2024 | NVO

Novo Nordisk free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.

  • Novo Nordisk annual free cash flow for 2023 was $12.066B, a 27.68% increase from 2022.
  • Novo Nordisk annual free cash flow for 2022 was $9.451B, a 22.06% increase from 2021.
  • Novo Nordisk annual free cash flow for 2021 was $7.743B, a 9.55% increase from 2020.

Novo Nordisk Free Cash Flow 2010-2024 | NVO

  • Novo Nordisk annual free cash flow for 2023 was $12.066B, a 27.68% increase from 2022.
  • Novo Nordisk annual free cash flow for 2022 was $9.451B, a 22.06% increase from 2021.
  • Novo Nordisk annual free cash flow for 2021 was $7.743B, a 9.55% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$755.3B
Johnson & Johnson (JNJ)$351.2B
AbbVie (ABBV)$318.1B
Merck (MRK)$251.6B
AstraZeneca (AZN)$205.6B
Novartis AG (NVS)$201B
Pfizer (PFE)$151.5B
Sanofi (SNY)$122.6B
Bayer (BAYRY)$19.1B
Innoviva (INVA)$1.1B